Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge.

Published

Journal Article

Three Indian rhesus macaques, Ad-SIV primed/protein boosted and exposed twice to high-dose mucosal SIV(mac251) challenges, exhibited elite control of viremia over 6.5 years. They were negative for host factors associated with control of SIV infection. After a third intrarectal challenge with SIV(smE660), all controlled viremia, with one (macaque #5) maintaining undetectable viremia in blood. Acquisition was not blocked, but virus was contained in the jejunum and draining lymph nodes. Polyfunctional memory T cell responses and high-titered neutralizing and non-neutralizing serum and mucosal antibodies were present before and maintained post-challenge. The level of protection seen for animal #5 was predicted from analyses of gene transcription in jejunum 2 weeks post-challenge. Macaques #7 and #9, exhibiting lower pre-challenge cellular and humoral immunity, partially controlled the SIV(smE660) challenge. Initial vaccine-induced control by macaque #5 extended to the SIV(smE660) challenge due to multiple immune mechanisms that were boosted and augmented by cryptic SIV exposure.

Full Text

Duke Authors

Cited Authors

  • Patterson, LJ; Daltabuit-Test, M; Xiao, P; Zhao, J; Hu, W; Wille-Reece, U; Brocca-Cofano, E; Kalyanaraman, VS; Kalisz, I; Whitney, S; Lee, EM; Pal, R; Montefiori, DC; Dandekar, S; Seder, R; Roederer, M; Wiseman, RW; Hirsch, V; Robert-Guroff, M

Published Date

  • March 1, 2011

Published In

Volume / Issue

  • 411 / 1

Start / End Page

  • 87 - 102

PubMed ID

  • 21237474

Pubmed Central ID

  • 21237474

Electronic International Standard Serial Number (EISSN)

  • 1096-0341

Digital Object Identifier (DOI)

  • 10.1016/j.virol.2010.12.033

Language

  • eng

Conference Location

  • United States